A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Phase 1/2 Unknown
172 enrolled
FIBROSARC US
Phase 2 Unknown
114 enrolled
Exploring Clinical Trial Experiences of People With Leiomyosarcoma
Unknown
500 enrolled
Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma
Phase NA Unknown
28 enrolled
MYOSARCII
Unknown
600 enrolled
MYOSARC
Unknown
1,000 enrolled
UN-RESARC
Phase 2 Unknown
46 enrolled
ADCVCTAST
Phase 1/2 Unknown
48 enrolled
CTCS
Unknown
20 enrolled
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
Phase 2 Unknown
118 enrolled
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Phase 2 Unknown
25 enrolled
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
Phase 2 Unknown
Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX
Unknown
400 enrolled